Please login to the form below
targeting
This page shows the latest targeting news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
AstraZeneca (AZ) and Daiichi Sankyo have shared positive results from a late-stage study of their investigational TROP2-targeting antibody drug conjugate, datopotamab deruxtecan, in certain breast cancer patients.
Latest news
-
Researchers discover how neurons die in Alzheimer’s disease
up promising avenues for potential therapies targeting AD, alongside traditional approaches aimed at amyloid and tau" and could lead to a "whole new line of drug development".
-
Bristol Myers Squibb reveals plans to double number of drugs in registrational trials
The pipeline update includes a CD19-directed cell therapy expanding into clinical trials for immunologic diseases, a GPRC5D-targeting cell therapy starting a registrational trial in relapsed/refractory multiple myeloma (RRMM), ... BMS, which already has
-
Moderna and Immatics announce oncology collaboration worth over $1.7bn
bispecifics (TCER) targeting cancer-specific HLA-presented peptides. ... mRNA-based cancer vaccines, as well as evaluate Immatics’s IMA203 TCR-T therapy targeting preferentially expressed antigen in melanoma (PRAME) in combination with Moderna’s
-
Novo Nordisk acquires Embark Biotech in deal worth over €470m
Novo gains access to Embark's lead asset targeting obesity and other cardiometabolic diseases. ... The transaction gives the Danish drugmaker full rights to develop and commercialise Embark Biotech's lead asset targeting obesity and other cardiometabolic
-
Pfizer and BioNTech’s XBB.1.5-adapted COVID-19 vaccine recommended by CHMP
The Vaccines and Related Biological Products advisory committee voted 21 to zero in favour of the monovalent XBB-lineage vaccines, and generally agreed that vaccines targeting the XBB.1.5 subvariant
More from news
Approximately 2 fully matching, plus 1,035 partially matching documents found.
Latest Intelligence
-
Creating the right foundations for omnichannel success
Where it does happen, teams will take a strong inside-out approach characterised by brand positioning and targeting.
-
Vive la différence: as Cannes celebrates life-changing creative, how did pharma do?
4. Creativity is targeting health inequity. Health equity has become a common theme for creative comms.
-
Resisting the resistance
It’s also important to understand which areas of the genome are more or less likely to change, as a drug targeting a highly mutable area may quickly become ineffective as
-
Creating truly effective communications – the impact of high speed, high octane messaging
Don’t hit and hope. Rogers, who has more than 20 years’ experience in healthcare research and consulting, believes investment in research across segmentation, targeting, profiling and creative development can boost
-
How innovation in healthcare is helping to drive behaviour change
Targeting support messaging around individual patient motivations, helping them to remain adherent.
More from intelligence
Approximately 1 fully matching, plus 180 partially matching documents found.
Latest appointments
-
New hires at Abbott, Kite and Arrakis Therapeutics
Arrakis Therapeutics . Arrakis Therapeutics, a biopharmaceutical company focused on the discovery of new-class small molecules medicines targeting RNA, has appointed Katrine Bosley (pictured below, right) as. ... Katrine’s experience building dynamic,
-
F-star hires ex-BMS immuno-oncology leader
Hewill oversee the clinical development of F-star’s lead product candidate, FS118, a LAG-3/PD-L1-targeting tetravalent bispecific antibody currently in aphase 1 clinical trial, recruiting the expansion
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
Under Bahija’s leadership, MedImmune significantly boosted its pipeline, expanding from 40 to more than 130 molecules in research and development targeting cancer; respiratory, inflammation, and autoimmunity; cardiovascular, renal and metabolic;
-
Industry appointments
Most recently, Hassan built the oncology-focused biology, preclinical and biomarker units for Immunocore, overseeing early development and the first-in-human trial of a TCR based biologic targeting a melanoma
-
Professor Thomas Cech joins Storm Therapeutics
mature into a world leading therapeutics company targeting RNA epigenetic modulation.”.
More from appointments
Approximately 0 fully matching, plus 21 partially matching documents found.
Latest from PMHub
-
Advertise to healthcare professionals with Springer Nature
Find out more about targeting our clinical science audiences ». 44 (0) 20 7843 4960. Address:. 4 Crinan Street. London. N1 9XW.
-
Going beyond the buzzword: omnichannel and healthcare marketing
interaction. For example, an approved email targeting a HCP’s individual needs will have a call to action to take them to a website for more detailed information.
-
Webcast: The virtual patient: How to use AI-powered conjoint to understand complex treatment decisions
choices, which segments they should be targeting, and the likely demand for their product profiles using the latest technologies and advanced analytical techniques.
-
Precision versus personalised medicine
Some are designed so that highly specific antigenic targeting allows for precise immune-mediated cell destruction.
-
Is communication failing us?
This confidence allows for better targeting of communication efforts, something that is efficient beyond simply cost.
More from PMHub
Approximately 2 fully matching, plus 81 partially matching documents found.
Subscribe to our email news alerts
- AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
- ICR and Merck renew strategic alliance for development of new cancer drugs
- DeepMind’s AI tool classifies effects of mutations in genetic diseases
- CDC awards over $23m to Johns Hopkins Center for Health Security project
- Looking to start activity on a currently unpromoted pharmaceutical brand?
- Considering a portfolio review?
No results were found
PMHub
Cuttsy + Cuttsy
Here at Cuttsy+Cuttsy, we believe in making the world a better place by bringing trusted, accessible information to all and...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
